KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

GoodRx Holdings (GDRX) EPS (Weighted Average and Diluted) (2019 - 2025)

Historic EPS (Weighted Average and Diluted) for GoodRx Holdings (GDRX) over the last 7 years, with Q3 2025 value amounting to $0.0.

  • GoodRx Holdings' EPS (Weighted Average and Diluted) fell 6903.9% to $0.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $0.09, marking a year-over-year increase of 40000.0%. This contributed to the annual value of $0.04 for FY2024, which is 30896.44% up from last year.
  • Latest data reveals that GoodRx Holdings reported EPS (Weighted Average and Diluted) of $0.0 as of Q3 2025, which was down 6903.9% from $0.04 recorded in Q2 2025.
  • GoodRx Holdings' EPS (Weighted Average and Diluted)'s 5-year high stood at $0.14 during Q2 2023, with a 5-year trough of -$0.1 in Q3 2022.
  • In the last 5 years, GoodRx Holdings' EPS (Weighted Average and Diluted) had a median value of $0.0 in 2024 and averaged -$0.0.
  • Data for GoodRx Holdings' EPS (Weighted Average and Diluted) shows a peak YoY increase of 428592.08% (in 2023) and a maximum YoY decrease of 50000.0% (in 2023) over the last 5 years.
  • Over the past 5 years, GoodRx Holdings' EPS (Weighted Average and Diluted) (Quarter) stood at -$0.09 in 2021, then skyrocketed by 88.89% to -$0.01 in 2022, then plummeted by 500.0% to -$0.06 in 2023, then soared by 128.64% to $0.02 in 2024, then tumbled by 81.99% to $0.0 in 2025.
  • Its EPS (Weighted Average and Diluted) stands at $0.0 for Q3 2025, versus $0.04 for Q2 2025 and $0.03 for Q1 2025.